Please Wait.....
Report
North America Hepatitis Delta Virus (HDV) Infection Market
Market Report I 2024-09-01 I 199 Pages I Data Bridge Market Research
The North America Hepatitis Delta Virus (HDV) infection market is expected to reach USD 9.49 million by 2031 from USD 6.83 million in 2023, growing with a CAGR of 4.4% in the forecast period of 2024 to 2031.
Market Segmentation:
North America Hepatitis Delta Virus (HDV) Infection Market, By Type (Acute Hepatitis D and Chronic Hepatitis D), Treatment (Surgery (Liver Transplant) and Medication), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral), Age Group (Adults, Geriatric, and Pediatric), Gender (Female and Male), Transmission (Contaminated Needles, Exposure to Infected Blood, Blood and Plasma Product Transfusion, and Others), End User (Hospitals, Specialty Clinics, Home Care Setting, Research Institutes and Academic Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) Countries (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031
Overview of North America Hepatitis Delta Virus (HDV) Infection Market Dynamics:
Driver
- Increasing prevalence of hepatitis
Restraint
- High cost of treatment
Opportunity
- Rising innovative drug development
Market Players:
The key market players operating in the North America Hepatitis Delta Virus (HDV) Infection market are listed below:
- Gilead Sciences Inc. (U.S.)
- Genentech Inc. (U.S.)
- Alnylam Pharmaceuticals Inc. (U.S.)
- Assembly Biosciences Inc. (U.S.)
- Eiger Pharmaceuticals (U.S.)
- GlobeImmune Inc. (U.S.)
- Huahui Health Ltd. (China)
- Johnson & Johnson Services Inc. (U.S.)
- PharmaEssentia Corporation (Taiwan)
- Replicor (Canada)
- Vir Biotechnology Inc. (U.S.)
1 INTRODUCTION 45
1.1 OBJECTIVES OF THE STUDY 45
1.2 MARKET DEFINITION 45
1.3 OVERVIEW OF THE NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET 45
1.4 CURRENCY AND PRICING 47
1.5 LIMITATIONS 47
1.6 MARKETS COVERED 47
2 MARKET SEGMENTATION 50
2.1 MARKETS COVERED 50
2.2 GEOGRAPHICAL SCOPE 51
2.3 YEARS CONSIDERED FOR THE STUDY 52
2.4 DBMR TRIPOD DATA VALIDATION MODEL 53
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 56
2.6 MULTIVARIATE MODELLING 57
2.7 MARKET END USER COVERAGE GRID 58
2.8 DBMR MARKET POSITION GRID 59
2.9 VENDOR SHARE ANALYSIS 60
2.10 SECONDARY SOURCES 61
2.11 ASSUMPTIONS 61
3 EXECUTIVE SUMMARY 62
4 PREMIUM INSIGHTS 66
4.1 PESTAL ANALYSIS 67
4.2 PORTER FIVE FORCES 68
4.3 NORTH AMERICA CLINICAL TRIAL MARKET FOR NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET 69
4.4 DISTRIBUTION OF PRODUCTS BY PHASE 76
5 EPIDEMIOLOGY 77
6 MARKET OVERVIEW 80
6.1 DRIVERS 82
6.1.1 GROWING PREVALENCE OF HEPATITIS 82
6.1.2 INCREASE IN HEALTHCARE EXPENDITURE 83
6.1.3 ONGOING RESEARCH AND DEVELOPMENT INITIATIVES 83
6.1.4 ADVANCES IN DIAGNOSTIC TECHNOLOGIES 84
6.2 RESTRAINTS 86
6.2.1 LIMITED AWARENESS OF HEPATITIS DELTA VIRUS (HDV) 86
6.2.2 HIGH COST OF TREATMENT 86
6.3 OPPORTUNITIES 88
6.3.1 RISING INNOVATIVE DRUG DEVELOPMENT 88
6.3.2 INCREASING DEVELOPMENT OF COMBINATION THERAPIES 90
6.3.3 GROWING ADVANCEMENTS IN DIGITAL HEALTH SOLUTIONS 91
6.4 CHALLENGES 92
6.4.1 SIDE EFFECTS OF CURRENT TREATMENTS 92
6.4.2 SLOW REGULATORY APPROVALS 93
7 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY TYPE 94
7.1 OVERVIEW 95
7.2 ACUTE HEPATITIS D 98
7.3 CHRONIC HEPATITIS D 98
8 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY TREATMENT 99
8.1 OVERVIEW 100
8.2 SURGERY (LIVER TRANSPLANT) 103
8.3 MEDICATION 103
8.3.1 APPROVED THERAPIES 104
8.3.1.1 PEGYLATED INTERFERON ALPHA 104
8.3.1.2 ENTRY INHIBITOR (BULEVIRTIDE) 104
8.3.2 EMERGING THERAPIES 104
9 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY DOSAGE FORM 105
9.1 OVERVIEW 106
9.2 TABLET 109
9.3 CAPSULE 109
9.4 INJECTABLE 110
10 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY DRUG TYPE 111
10.1 OVERVIEW 112
10.2 BRANDED 115
10.3 GENERIC 115
11 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY ROUTE OF ADMINISTRATION 116
11.1 OVERVIEW 117
11.2 ORAL 120
11.2.1 TABLET 120
11.2.2 CAPSULE 120
11.2.3 OTHERS 120
11.3 PARENTERAL 121
12 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY GENDER 122
12.1 OVERVIEW 123
12.2 FEMALE 126
12.3 MALE 126
13 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY AGE GROUP 127
13.1 OVERVIEW 128
13.2 ADULTS 131
13.3 GERIATRIC 131
13.4 PEDIATRIC 132
14 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY TRANSMISSION 133
14.1 OVERVIEW 134
14.2 CONTAMINATED NEEDLES 137
14.3 EXPOSURE TO INFECTED BLOOD 137
14.4 BLOOD AND PLASMA PRODUCT TRANSFUSION 138
14.5 OTHERS 138
15 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY END USER 139
15.1 OVERVIEW 140
15.2 HOSPITALS 143
15.3 SPECIALTY CENTERS 143
15.4 HOME CARE SETTING 144
15.5 RESEARCH INSTITUTES & ACADEMIC CENTERS 144
15.6 AMBULATORY SURGICAL CENTERS 145
15.7 OTHERS 145
16 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY DISTRIBUTION CHANNEL 146
16.1 OVERVIEW 147
16.2 DIRECT TENDER 150
16.3 RETAIL SALES 150
16.3.1 HOSPITAL PHARMACY 151
16.3.2 RETAIL PHARMACY 151
16.3.3 ONLINE PHARMACY 151
16.4 OTHERS 151
17 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET, BY REGION 152
17.1 NORTH AMERICA 155
17.1.1 U.S. 159
17.1.2 CANADA 163
17.1.3 MEXICO 167
18 NORTH AMERICA HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET: COMPANY LANDSCAPE 171
18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
19 SWOT ANALYSIS 172
20 COMPANY PROFILE 173
20.1 GILEAD SCIENCES, INC. 173
20.1.1 COMPANY SNAPSHOT 173
20.1.2 REVENUE ANALYSIS 174
20.1.3 COMPANY SHARE ANALYSIS 174
20.1.4 PIPELINE PRODUCT 175
20.1.5 RECENT DEVELOPMENTS 175
20.2 GENENTECH, INC. 177
20.2.1 COMPANY SNAPSHOT 177
20.2.2 PRODUCT PORTFOLIO 177
20.2.3 RECENT DEVELOPMENT 177
20.3 ALNYLAM PHARMACEUTICALS, INC. 178
20.3.1 COMPANY SNAPSHOT 178
20.3.2 REVENUE ANALYSIS 178
20.3.3 PIPELINE PRODUCT 179
20.3.4 RECENT DEVELOPMENTS 179
20.4 ASSEMBLY BIOSCIENCES, INC. 180
20.4.1 COMPANY SNAPSHOT 180
20.4.2 REVENUE ANALYSIS 180
20.4.3 PIPELINE PRODUCT 181
20.4.4 RECENT DEVELOPMENTS 181
20.5 EIGER BIOPHARMACEUTICALS 182
20.5.1 COMPANY SNAPSHOT 182
20.5.2 REVENUE ANALYSIS 182
20.5.3 COMPANY SHARE ANALYSIS 183
20.5.4 PRODUCT PORTFOLIO 183
20.5.5 PIPELINE PRODUCT 183
20.5.6 RECENT DEVELOPMENT 184
20.6 GLOBEIMMUNE INC. 185
20.6.1 COMPANY SNAPSHOT 185
20.6.2 PIPELINE PRODUCT 185
20.6.3 RECENT DEVELOPMENT 185
20.7 HUAHUI HEALTH LTD. 186
20.7.1 COMPANY SNAPSHOT 186
20.7.2 PIPELINE PRODUCT 186
20.7.3 RECENT DEVELOPMENT 186
20.8 JOHNSON & JOHNSON SERVICES, INC. 187
20.8.1 COMPANY SNAPSHOT 187
20.8.2 REVENUE ANALYSIS 187
20.8.3 PIPELINE PRODUCT 188
20.8.4 RECENT DEVELOPMENT 188
20.9 PHARMAESSENTIA CORPORATION 189
20.9.1 COMPANY SNAPSHOT 189
20.9.2 REVENUE ANALYSIS 189
20.9.3 PIPELINE PRODUCT 190
20.9.4 RECENT DEVELOPMENT 190
20.10 REPLICOR 191
20.10.1 COMPANY SNAPSHOT 191
20.10.2 PIPELINE PRODUCT 191
20.10.3 RECENT DEVELOPMENTS 192
20.11 VIR BIOTECHNOLOGY, INC. 193
20.11.1 COMPANY SNAPSHOT 193
20.11.2 REVENUE ANALAYSIS 193
20.11.3 PRODUCT PIPELINE 194
20.11.4 RECENT DEVELOPMENTS 194
21 QUESTIONNAIRE 195
22 RELATED REPORTS 199
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security